Skip to main content

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.

Publication ,  Journal Article
Kim, S-Y; Le Rademacher, J; Antin, JH; Anderlini, P; Ayas, M; Battiwalla, M; Carreras, J; Kurtzberg, J; Nakamura, R; Eapen, M; Deeg, HJ
Published in: Haematologica
December 2014

A proportion of patients with aplastic anemia who are treated with immunosuppressive therapy develop clonal hematologic disorders, including post-aplastic anemia myelodysplastic syndrome. Many will proceed to allogeneic hematopoietic stem cell transplantation. We identified 123 patients with post-aplastic anemia myelodysplastic syndrome who from 1991 through 2011 underwent allogeneic hematopoietic stem cell transplantation, and in a matched-pair analysis compared outcome to that in 393 patients with de novo myelodysplastic syndrome. There was no difference in overall survival. There were no significant differences with regard to 5-year probabilities of relapse, non-relapse mortality, relapse-free survival and overall survival; these were 14%, 40%, 46% and 49% for post-aplastic anemia myelodysplastic syndrome, and 20%, 33%, 47% and 49% for de novo myelodysplastic syndrome, respectively. In multivariate analysis, relapse (hazard ratio 0.71; P=0.18), non-relapse mortality (hazard ratio 1.28; P=0.18), relapse-free survival (hazard ratio 0.97; P=0.80) and overall survival (hazard ratio 1.02; P=0.88) of post-aplastic anemia myelodysplastic syndrome were similar to those of patients with de novo myelodysplastic syndrome. Cytogenetic risk was independently associated with overall survival in both groups. Thus, transplant success in patients with post-aplastic anemia myelodysplastic syndrome was similar to that in patients with de novo myelodysplastic syndrome, and cytogenetics was the only significant prognostic factor for post-aplastic anemia myelodysplastic syndrome patients.

Duke Scholars

Published In

Haematologica

DOI

EISSN

1592-8721

Publication Date

December 2014

Volume

99

Issue

12

Start / End Page

1868 / 1875

Location

Italy

Related Subject Headings

  • Young Adult
  • Transplantation, Homologous
  • Transplantation Conditioning
  • Survival Rate
  • Recurrence
  • Prognosis
  • Neoplasm Staging
  • Myelodysplastic Syndromes
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kim, S.-Y., Le Rademacher, J., Antin, J. H., Anderlini, P., Ayas, M., Battiwalla, M., … Deeg, H. J. (2014). Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. Haematologica, 99(12), 1868–1875. https://doi.org/10.3324/haematol.2014.108977
Kim, Sung-Yong, Jennifer Le Rademacher, Joseph H. Antin, Paolo Anderlini, Mouhab Ayas, Minoo Battiwalla, Jeanette Carreras, et al. “Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.Haematologica 99, no. 12 (December 2014): 1868–75. https://doi.org/10.3324/haematol.2014.108977.
Kim S-Y, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, et al. Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. Haematologica. 2014 Dec;99(12):1868–75.
Kim, Sung-Yong, et al. “Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation.Haematologica, vol. 99, no. 12, Dec. 2014, pp. 1868–75. Pubmed, doi:10.3324/haematol.2014.108977.
Kim S-Y, Le Rademacher J, Antin JH, Anderlini P, Ayas M, Battiwalla M, Carreras J, Kurtzberg J, Nakamura R, Eapen M, Deeg HJ. Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation. Haematologica. 2014 Dec;99(12):1868–1875.

Published In

Haematologica

DOI

EISSN

1592-8721

Publication Date

December 2014

Volume

99

Issue

12

Start / End Page

1868 / 1875

Location

Italy

Related Subject Headings

  • Young Adult
  • Transplantation, Homologous
  • Transplantation Conditioning
  • Survival Rate
  • Recurrence
  • Prognosis
  • Neoplasm Staging
  • Myelodysplastic Syndromes
  • Middle Aged
  • Male